VentureLabs Portfolio

Current Portfolio

Company Description Statussort icon Initial Date
<a href="/venture-capital/all-companies/eleven-biotherapeutics-inc">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. Public 2008 View Profile
<a href="/venture-capital/all-companies/seres-therapeutics">Seres Therapeutics</a> Developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. Public 2012 View Profile
<a href="/venture-capital/all-companies/ensemble-therapeutics-corporation">Ensemble Therapeutics Corporation</a> Discovering and developing novel small molecule therapies for cancer and other serious diseases. Private 2004 View Profile
<a href="/venture-capital/all-companies/axcella-health">Axcella Health</a> Pioneering revolutionary new medicines with a focus on amino acid homeostasis. Private 2010 View Profile
<a href="/venture-capital/all-companies/moderna">Moderna</a> Pioneering messenger RNA Therapeutics™, an entirely new in vivo drug modality. Private 2010 View Profile
<a href="/venture-capital/all-companies/permeon-biologics-inc">Permeon Biologics Inc.</a> Pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Private 2011 View Profile
<a href="/venture-capital/all-companies/syros-pharmaceuticals-0">Syros Pharmaceuticals</a> Harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Private 2012 View Profile
<a href="/venture-capital/all-companies/evelo-biosciences">Evelo Biosciences</a> Transforming cancer therapy through a deep understanding of the cancer microbiome. Private 2015 View Profile
<a href="/venture-capital/all-companies/codiak-biosciences">Codiak BioSciences</a> Leading developer of exosome-based diagnostics and therapeutics. Private 2015 View Profile
<a href="/venture-capital/all-companies/kaleido-biosciences">Kaleido BioSciences</a> Private 2015 View Profile
<a href="/venture-capital/all-companies/rubius-therapeutics">Rubius Therapeutics</a> Pioneering a new therapeutic modality using genetically modified red blood cells to create Red-Cell Therapeutics™ with the potential to treat diverse areas of high unmet medical need. Private 2014 View Profile
<a href="/venture-capital/all-companies/cadena-bio">Cadena Bio</a> Cadena Bio is developing revolutionary ingredients that feed and nourish the human microbiome. Private 2016 View Profile